The colorectal cancer diagnostics market can be segmented by test type into various categories such as blood test, stool test, fecal occult blood test, fecal biomarker test, CRC DNA screening test, imaging test (including computed tomography scan, ultrasound, magnetic resonance imaging scan, positron emission tomography scan, colonoscopy, and other imaging tests), biopsy, and other test types.
End-use
The end-use segment of the colorectal cancer diagnostics market includes hospitals, diagnostic imaging centers, cancer research centers, and other healthcare facilities. Each of these end-users plays a crucial role in the diagnosis and treatment of colorectal cancer, with hospitals being the primary setting for most diagnostic procedures and treatment interventions. Diagnostic imaging centers specialize in providing imaging tests such as CT scans, MRIs, and PET scans, while cancer research centers focus on the development of innovative diagnostic tools and therapeutic strategies for colorectal cancer. Other healthcare facilities also contribute to the overall management of colorectal cancer by offering specialized services and support to patients and healthcare providers.